PCR and NGS-Based Molecular Diagnostics Market 2028 Product and Service, Application, End User and Geography | The Insight Partners

    PCR and NGS-Based Molecular Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product and Service (Reagents and Kits, Instruments, Service and Software); Application (Infectious Disease, Oncology, Genetic Test, Others); End User (Hospital and Academic Lboratories, Reference Laboratories, Other) and Geography

    Report Code: TIPRE00014426 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming

    MARKET INTRODUCTION

    Molecular diagnostics includes various techniques to analyze biological markers in the genome and proteome. These techniques are used to guide patient's right from diagnosis to treatment, for diseases like cancer, infectious disease, and congenital abnormalities. These techniques help in identifying the genetic variants that have led to the disease. Molecular diagnostic procedures that are routinely used include polymerase chain reaction (PCR), real-time PCR, restriction fragment length polymorphism analysis (RFLP), fluorescence in situ hybridization, gel electrophoresis, single-stranded conformation polymorphism, hybrid capture, and other assays.

    MARKET DYNAMICS

    The PCR and NGS-Based Molecular Diagnostics Market is growing due to increasing prevalence of infectious diseases and different types of cancers, increasing awareness and acceptance of personalized medicine and companion diagnostics, growth in the biomarker identification market and advancements in molecular techniques. However, technical issues related to sample collection and storage and risk of contamination and complex regulatory scenario hampers growth of this market.

    MARKET SCOPE

    The "PCR and NGS-Based Molecular Diagnostics Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of PCR and NGS-Based Molecular Diagnostics market with detailed market segmentation by product and service, application and end user. The PCR and NGS-Based Molecular Diagnostics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in PCR and NGS-Based Molecular Diagnostics Market and offers key trends and opportunities in the market.

    MARKET SEGMENTATION

    The PCR and NGS-based molecular diagnostics market is segmented on the basis of product and service, application and end user. Based on product and service, the market is segmented as reagents & kits, instruments and services & software. On the basis of application, the market is categorized as infectious disease and oncology, genetic test and others. Based on end user the market is segmented into hospital & academic laboratories, reference laboratories and other

    REGIONAL FRAMEWORK

    The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the PCR and NGS-Based Molecular Diagnostics Market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The PCR and NGS-Based Molecular Diagnostics Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

    `The report analyzes factors affecting PCR and NGS-Based Molecular Diagnostics Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the PCR and NGS-Based Molecular Diagnostics Market in these regions.



    Get more information on this report :

    MARKET PLAYERS


    The report covers key developments in the PCR and NGS-Based Molecular Diagnostics Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from PCR and NGS-Based Molecular Diagnostics Market are anticipated to have lucrative growth opportunities in the future with the rising demand for PCR and NGS-Based Molecular Diagnostics Market in the global market. Below mentioned is the list of few companies engaged in the PCR and NGS-Based Molecular Diagnostics Market.

    The report also includes the profiles of key players in PCR and NGS-Based Molecular Diagnostics Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

    •  Abbott
    •  Agilent Technologies, Inc.
    •  Thermo Fisher Scientific Inc.
    •  F. Hoffmann-La Roche Ltd.
    •  Bio-Rad Laboratories, Inc.
    •  QIAGEN
    •  bioMérieux SA
    •  BD
    •  Illumina, Inc.
    •  Danaher

    The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


    Get more information on this report :

    TABLE OF CONTENTS


    1. INTRODUCTION
    1.1. SCOPE OF THE STUDY
    1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
    1.3. MARKET SEGMENTATION
    1.3.1 PCR And NGS-Based Molecular Diagnostics Market - By Product and Service
    1.3.2 PCR And NGS-Based Molecular Diagnostics Market - By Application
    1.3.3 PCR And NGS-Based Molecular Diagnostics Market - By End User
    1.3.4 PCR And NGS-Based Molecular Diagnostics Market - By Region
    1.3.4.1 By Country

    2. KEY TAKEAWAYS

    3. RESEARCH METHODOLOGY

    4. PCR AND NGS-BASED MOLECULAR DIAGNOSTICS MARKET LANDSCAPE
    4.1. OVERVIEW
    4.2. PEST ANALYSIS
    4.2.1 North America - Pest Analysis
    4.2.2 Europe - Pest Analysis
    4.2.3 Asia-Pacific - Pest Analysis
    4.2.4 Middle East and Africa - Pest Analysis
    4.2.5 South and Central America - Pest Analysis
    4.3. EXPERT OPINIONS

    5. PCR AND NGS-BASED MOLECULAR DIAGNOSTICS MARKET - KEY MARKET DYNAMICS
    5.1. KEY MARKET DRIVERS
    5.2. KEY MARKET RESTRAINTS
    5.3. KEY MARKET OPPORTUNITIES
    5.4. FUTURE TRENDS
    5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

    6. PCR AND NGS-BASED MOLECULAR DIAGNOSTICS MARKET - GLOBAL MARKET ANALYSIS
    6.1. PCR AND NGS-BASED MOLECULAR DIAGNOSTICS - GLOBAL MARKET OVERVIEW
    6.2. PCR AND NGS-BASED MOLECULAR DIAGNOSTICS - GLOBAL MARKET AND FORECAST TO 2028
    6.3. MARKET POSITIONING/MARKET SHARE

    7. PCR AND NGS-BASED MOLECULAR DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT AND SERVICE
    7.1. OVERVIEW
    7.2. PRODUCT AND SERVICE MARKET FORECASTS AND ANALYSIS
    7.3. REAGENTS AND KITS
    7.3.1. Overview
    7.3.2. Reagents and Kits Market Forecast and Analysis
    7.4. INSTRUMENTS
    7.4.1. Overview
    7.4.2. Instruments Market Forecast and Analysis
    7.5. SERVICE AND SOFTWARE
    7.5.1. Overview
    7.5.2. Service and Software Market Forecast and Analysis
    8. PCR AND NGS-BASED MOLECULAR DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
    8.1. OVERVIEW
    8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
    8.3. INFECTIOUS DISEASE
    8.3.1. Overview
    8.3.2. Infectious Disease Market Forecast and Analysis
    8.4. ONCOLOGY
    8.4.1. Overview
    8.4.2. Oncology Market Forecast and Analysis
    8.5. GENETIC TEST
    8.5.1. Overview
    8.5.2. Genetic Test Market Forecast and Analysis
    8.6. OTHERS
    8.6.1. Overview
    8.6.2. Others Market Forecast and Analysis
    9. PCR AND NGS-BASED MOLECULAR DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2028 - END USER
    9.1. OVERVIEW
    9.2. END USER MARKET FORECASTS AND ANALYSIS
    9.3. HOSPITAL AND ACADEMIC LBORATORIES
    9.3.1. Overview
    9.3.2. Hospital and Academic Lboratories Market Forecast and Analysis
    9.4. REFERENCE LABORATORIES
    9.4.1. Overview
    9.4.2. Reference Laboratories Market Forecast and Analysis
    9.5. OTHER
    9.5.1. Overview
    9.5.2. Other Market Forecast and Analysis

    10. PCR AND NGS-BASED MOLECULAR DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
    10.1. NORTH AMERICA
    10.1.1 North America PCR And NGS-Based Molecular Diagnostics Market Overview
    10.1.2 North America PCR And NGS-Based Molecular Diagnostics Market Forecasts and Analysis
    10.1.3 North America PCR And NGS-Based Molecular Diagnostics Market Forecasts and Analysis - By Product and Service
    10.1.4 North America PCR And NGS-Based Molecular Diagnostics Market Forecasts and Analysis - By Application
    10.1.5 North America PCR And NGS-Based Molecular Diagnostics Market Forecasts and Analysis - By End User
    10.1.6 North America PCR And NGS-Based Molecular Diagnostics Market Forecasts and Analysis - By Countries
    10.1.6.1 United States PCR And NGS-Based Molecular Diagnostics Market
    10.1.6.1.1 United States PCR And NGS-Based Molecular Diagnostics Market by Product and Service
    10.1.6.1.2 United States PCR And NGS-Based Molecular Diagnostics Market by Application
    10.1.6.1.3 United States PCR And NGS-Based Molecular Diagnostics Market by End User
    10.1.6.2 Canada PCR And NGS-Based Molecular Diagnostics Market
    10.1.6.2.1 Canada PCR And NGS-Based Molecular Diagnostics Market by Product and Service
    10.1.6.2.2 Canada PCR And NGS-Based Molecular Diagnostics Market by Application
    10.1.6.2.3 Canada PCR And NGS-Based Molecular Diagnostics Market by End User
    10.1.6.3 Mexico PCR And NGS-Based Molecular Diagnostics Market
    10.1.6.3.1 Mexico PCR And NGS-Based Molecular Diagnostics Market by Product and Service
    10.1.6.3.2 Mexico PCR And NGS-Based Molecular Diagnostics Market by Application
    10.1.6.3.3 Mexico PCR And NGS-Based Molecular Diagnostics Market by End User
    10.2. EUROPE
    10.2.1 Europe PCR And NGS-Based Molecular Diagnostics Market Overview
    10.2.2 Europe PCR And NGS-Based Molecular Diagnostics Market Forecasts and Analysis
    10.2.3 Europe PCR And NGS-Based Molecular Diagnostics Market Forecasts and Analysis - By Product and Service
    10.2.4 Europe PCR And NGS-Based Molecular Diagnostics Market Forecasts and Analysis - By Application
    10.2.5 Europe PCR And NGS-Based Molecular Diagnostics Market Forecasts and Analysis - By End User
    10.2.6 Europe PCR And NGS-Based Molecular Diagnostics Market Forecasts and Analysis - By Countries
    10.2.6.1 Germany PCR And NGS-Based Molecular Diagnostics Market
    10.2.6.1.1 Germany PCR And NGS-Based Molecular Diagnostics Market by Product and Service
    10.2.6.1.2 Germany PCR And NGS-Based Molecular Diagnostics Market by Application
    10.2.6.1.3 Germany PCR And NGS-Based Molecular Diagnostics Market by End User
    10.2.6.2 France PCR And NGS-Based Molecular Diagnostics Market
    10.2.6.2.1 France PCR And NGS-Based Molecular Diagnostics Market by Product and Service
    10.2.6.2.2 France PCR And NGS-Based Molecular Diagnostics Market by Application
    10.2.6.2.3 France PCR And NGS-Based Molecular Diagnostics Market by End User
    10.2.6.3 Italy PCR And NGS-Based Molecular Diagnostics Market
    10.2.6.3.1 Italy PCR And NGS-Based Molecular Diagnostics Market by Product and Service
    10.2.6.3.2 Italy PCR And NGS-Based Molecular Diagnostics Market by Application
    10.2.6.3.3 Italy PCR And NGS-Based Molecular Diagnostics Market by End User
    10.2.6.4 Spain PCR And NGS-Based Molecular Diagnostics Market
    10.2.6.4.1 Spain PCR And NGS-Based Molecular Diagnostics Market by Product and Service
    10.2.6.4.2 Spain PCR And NGS-Based Molecular Diagnostics Market by Application
    10.2.6.4.3 Spain PCR And NGS-Based Molecular Diagnostics Market by End User
    10.2.6.5 United Kingdom PCR And NGS-Based Molecular Diagnostics Market
    10.2.6.5.1 United Kingdom PCR And NGS-Based Molecular Diagnostics Market by Product and Service
    10.2.6.5.2 United Kingdom PCR And NGS-Based Molecular Diagnostics Market by Application
    10.2.6.5.3 United Kingdom PCR And NGS-Based Molecular Diagnostics Market by End User
    10.3. ASIA-PACIFIC
    10.3.1 Asia-Pacific PCR And NGS-Based Molecular Diagnostics Market Overview
    10.3.2 Asia-Pacific PCR And NGS-Based Molecular Diagnostics Market Forecasts and Analysis
    10.3.3 Asia-Pacific PCR And NGS-Based Molecular Diagnostics Market Forecasts and Analysis - By Product and Service
    10.3.4 Asia-Pacific PCR And NGS-Based Molecular Diagnostics Market Forecasts and Analysis - By Application
    10.3.5 Asia-Pacific PCR And NGS-Based Molecular Diagnostics Market Forecasts and Analysis - By End User
    10.3.6 Asia-Pacific PCR And NGS-Based Molecular Diagnostics Market Forecasts and Analysis - By Countries
    10.3.6.1 Australia PCR And NGS-Based Molecular Diagnostics Market
    10.3.6.1.1 Australia PCR And NGS-Based Molecular Diagnostics Market by Product and Service
    10.3.6.1.2 Australia PCR And NGS-Based Molecular Diagnostics Market by Application
    10.3.6.1.3 Australia PCR And NGS-Based Molecular Diagnostics Market by End User
    10.3.6.2 China PCR And NGS-Based Molecular Diagnostics Market
    10.3.6.2.1 China PCR And NGS-Based Molecular Diagnostics Market by Product and Service
    10.3.6.2.2 China PCR And NGS-Based Molecular Diagnostics Market by Application
    10.3.6.2.3 China PCR And NGS-Based Molecular Diagnostics Market by End User
    10.3.6.3 India PCR And NGS-Based Molecular Diagnostics Market
    10.3.6.3.1 India PCR And NGS-Based Molecular Diagnostics Market by Product and Service
    10.3.6.3.2 India PCR And NGS-Based Molecular Diagnostics Market by Application
    10.3.6.3.3 India PCR And NGS-Based Molecular Diagnostics Market by End User
    10.3.6.4 Japan PCR And NGS-Based Molecular Diagnostics Market
    10.3.6.4.1 Japan PCR And NGS-Based Molecular Diagnostics Market by Product and Service
    10.3.6.4.2 Japan PCR And NGS-Based Molecular Diagnostics Market by Application
    10.3.6.4.3 Japan PCR And NGS-Based Molecular Diagnostics Market by End User
    10.3.6.5 South Korea PCR And NGS-Based Molecular Diagnostics Market
    10.3.6.5.1 South Korea PCR And NGS-Based Molecular Diagnostics Market by Product and Service
    10.3.6.5.2 South Korea PCR And NGS-Based Molecular Diagnostics Market by Application
    10.3.6.5.3 South Korea PCR And NGS-Based Molecular Diagnostics Market by End User
    10.4. MIDDLE EAST AND AFRICA
    10.4.1 Middle East and Africa PCR And NGS-Based Molecular Diagnostics Market Overview
    10.4.2 Middle East and Africa PCR And NGS-Based Molecular Diagnostics Market Forecasts and Analysis
    10.4.3 Middle East and Africa PCR And NGS-Based Molecular Diagnostics Market Forecasts and Analysis - By Product and Service
    10.4.4 Middle East and Africa PCR And NGS-Based Molecular Diagnostics Market Forecasts and Analysis - By Application
    10.4.5 Middle East and Africa PCR And NGS-Based Molecular Diagnostics Market Forecasts and Analysis - By End User
    10.4.6 Middle East and Africa PCR And NGS-Based Molecular Diagnostics Market Forecasts and Analysis - By Countries
    10.4.6.1 South Africa PCR And NGS-Based Molecular Diagnostics Market
    10.4.6.1.1 South Africa PCR And NGS-Based Molecular Diagnostics Market by Product and Service
    10.4.6.1.2 South Africa PCR And NGS-Based Molecular Diagnostics Market by Application
    10.4.6.1.3 South Africa PCR And NGS-Based Molecular Diagnostics Market by End User
    10.4.6.2 Saudi Arabia PCR And NGS-Based Molecular Diagnostics Market
    10.4.6.2.1 Saudi Arabia PCR And NGS-Based Molecular Diagnostics Market by Product and Service
    10.4.6.2.2 Saudi Arabia PCR And NGS-Based Molecular Diagnostics Market by Application
    10.4.6.2.3 Saudi Arabia PCR And NGS-Based Molecular Diagnostics Market by End User
    10.4.6.3 U.A.E PCR And NGS-Based Molecular Diagnostics Market
    10.4.6.3.1 U.A.E PCR And NGS-Based Molecular Diagnostics Market by Product and Service
    10.4.6.3.2 U.A.E PCR And NGS-Based Molecular Diagnostics Market by Application
    10.4.6.3.3 U.A.E PCR And NGS-Based Molecular Diagnostics Market by End User
    10.5. SOUTH AND CENTRAL AMERICA
    10.5.1 South and Central America PCR And NGS-Based Molecular Diagnostics Market Overview
    10.5.2 South and Central America PCR And NGS-Based Molecular Diagnostics Market Forecasts and Analysis
    10.5.3 South and Central America PCR And NGS-Based Molecular Diagnostics Market Forecasts and Analysis - By Product and Service
    10.5.4 South and Central America PCR And NGS-Based Molecular Diagnostics Market Forecasts and Analysis - By Application
    10.5.5 South and Central America PCR And NGS-Based Molecular Diagnostics Market Forecasts and Analysis - By End User
    10.5.6 South and Central America PCR And NGS-Based Molecular Diagnostics Market Forecasts and Analysis - By Countries
    10.5.6.1 Brazil PCR And NGS-Based Molecular Diagnostics Market
    10.5.6.1.1 Brazil PCR And NGS-Based Molecular Diagnostics Market by Product and Service
    10.5.6.1.2 Brazil PCR And NGS-Based Molecular Diagnostics Market by Application
    10.5.6.1.3 Brazil PCR And NGS-Based Molecular Diagnostics Market by End User
    10.5.6.2 Argentina PCR And NGS-Based Molecular Diagnostics Market
    10.5.6.2.1 Argentina PCR And NGS-Based Molecular Diagnostics Market by Product and Service
    10.5.6.2.2 Argentina PCR And NGS-Based Molecular Diagnostics Market by Application
    10.5.6.2.3 Argentina PCR And NGS-Based Molecular Diagnostics Market by End User

    11. INDUSTRY LANDSCAPE
    11.1. MERGERS AND ACQUISITIONS
    11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
    11.3. NEW PRODUCT LAUNCHES
    11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

    12. PCR AND NGS-BASED MOLECULAR DIAGNOSTICS MARKET, KEY COMPANY PROFILES
    12.1. ABBOTT
    12.1.1. Key Facts
    12.1.2. Business Description
    12.1.3. Products and Services
    12.1.4. Financial Overview
    12.1.5. SWOT Analysis
    12.1.6. Key Developments
    12.2. AGILENT TECHNOLOGIES, INC.
    12.2.1. Key Facts
    12.2.2. Business Description
    12.2.3. Products and Services
    12.2.4. Financial Overview
    12.2.5. SWOT Analysis
    12.2.6. Key Developments
    12.3. THERMO FISHER SCIENTIFIC INC.
    12.3.1. Key Facts
    12.3.2. Business Description
    12.3.3. Products and Services
    12.3.4. Financial Overview
    12.3.5. SWOT Analysis
    12.3.6. Key Developments
    12.4. F. HOFFMANN-LA ROCHE LTD.
    12.4.1. Key Facts
    12.4.2. Business Description
    12.4.3. Products and Services
    12.4.4. Financial Overview
    12.4.5. SWOT Analysis
    12.4.6. Key Developments
    12.5. BIO-RAD LABORATORIES, INC.
    12.5.1. Key Facts
    12.5.2. Business Description
    12.5.3. Products and Services
    12.5.4. Financial Overview
    12.5.5. SWOT Analysis
    12.5.6. Key Developments
    12.6. QIAGEN
    12.6.1. Key Facts
    12.6.2. Business Description
    12.6.3. Products and Services
    12.6.4. Financial Overview
    12.6.5. SWOT Analysis
    12.6.6. Key Developments
    12.7. BIOMéRIEUX SA
    12.7.1. Key Facts
    12.7.2. Business Description
    12.7.3. Products and Services
    12.7.4. Financial Overview
    12.7.5. SWOT Analysis
    12.7.6. Key Developments
    12.8. BD
    12.8.1. Key Facts
    12.8.2. Business Description
    12.8.3. Products and Services
    12.8.4. Financial Overview
    12.8.5. SWOT Analysis
    12.8.6. Key Developments
    12.9. ILLUMINA, INC.
    12.9.1. Key Facts
    12.9.2. Business Description
    12.9.3. Products and Services
    12.9.4. Financial Overview
    12.9.5. SWOT Analysis
    12.9.6. Key Developments
    12.10. DANAHER
    12.10.1. Key Facts
    12.10.2. Business Description
    12.10.3. Products and Services
    12.10.4. Financial Overview
    12.10.5. SWOT Analysis
    12.10.6. Key Developments

    13. APPENDIX
    13.1. ABOUT THE INSIGHT PARTNERS
    13.2. GLOSSARY OF TERMS
    The List of Companies

    1. Abbott
    2. Agilent Technologies, Inc.
    3. Thermo Fisher Scientific Inc.
    4. F. Hoffmann-La Roche Ltd.
    5. Bio-Rad Laboratories, Inc.
    6. QIAGEN
    7. bioMérieux SA
    8. BD
    9. Illumina, Inc.
    10. Danaher
    TIPRE00014426
    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Get the Latest COVID-19 Analysis on this market




    Have a question?

    Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.


    Speak To Analyst
    Pricing
    • $3000
    • $4550
    • $6550
    • $8550
        GET FREE SAMPLE PDF

    Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

        Inquire for Discount